Benzinga - Mon, 12 Apr 2021 16:42:44 -0400
Benzinga - Fri, 09 Apr 2021 15:03:33 -0400
Benzinga - Fri, 09 Apr 2021 09:51:10 -0400
Benzinga - Mon, 05 Apr 2021 09:37:50 -0400
Benzinga - Mon, 05 Apr 2021 09:02:00 -0400
Benzinga - Thu, 25 Mar 2021 16:00:02 -0400
Benzinga - Thu, 25 Mar 2021 14:45:29 -0400
Benzinga - Wed, 24 Mar 2021 12:15:26 -0400
Benzinga - Wed, 24 Mar 2021 12:14:07 -0400
Benzinga - Wed, 24 Mar 2021 09:02:18 -0400
Benzinga - Tue, 23 Mar 2021 19:12:00 -0400
Benzinga - Tue, 23 Mar 2021 12:38:12 -0400
Benzinga - Thu, 18 Mar 2021 09:02:27 -0400
Benzinga - Tue, 09 Mar 2021 16:10:17 -0400
Benzinga - Tue, 09 Mar 2021 10:01:19 -0400
load more
Sector: Health Care.Industry: Biotechnology
Sorrento Therapeutics Inc is a biotechnology company focused on the development of novel immunotherapies for oncology and autoimmune/inflammation diseases. The antibody technologies target various locations: extracellular, intracellular, and membrane-bound antigens. The product portfolio consists of BioSimilar/BioBetter antibodies, CAR-T programs for treatment of solid tumors, adoptive cellular therapies, immuno-oncology mAbs, and antibody drug conjugates.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-10
REV
Q4 2020Est.ActualSurprise
EPS-0.250
REV11.505M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
SRNESorrento Therapeutics-7.59%1.9B

Sorrento Therapeutics Company Questions & Answers

Q

How do I buy Sorrento Therapeutics (SRNE) stock?

A

You can purchase shares of Sorrento Therapeutics (NASDAQ: SRNE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Sorrento Therapeutics's (SRNE) main competitors?

A

Other companies in Sorrento Therapeutics’s space includes: Burning Rock Biotech (NASDAQ:BNR), ADC Therapeutics (NYSE:ADCT) and FibroGen (NASDAQ:FGEN).

Q

What is the target price for Sorrento Therapeutics?

A

The latest price target for Sorrento Therapeutics (NASDAQ: SRNE) was reported by Alliance Global Partners on 2021-01-21. The analyst firm set a price target for 35.00 expecting SRNE to rise to within 12 months (a possible 404.32% upside). 3 analyst firms have reported ratings in the last year.

Q

How much is Sorrento Therapeutics (SRNE) stock ?

A

The stock price for Sorrento Therapeutics (NASDAQ: SRNE) is $6.94 last updated Mon Apr 12 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Sorrento Therapeutics (SRNE) dividend?

A

There are no upcoming dividends for Sorrento Therapeutics.

Q

When is Sorrento Therapeutics (NASDAQ:SRNE) reporting earnings?

A
Sorrento Therapeutics’s Q1 earnings are confirmed from now on May 10, 2021.
Q

When is the upcoming split for SRNE?

A

There is no upcoming split for Sorrento Therapeutics.